AMPK-mediated pioglitazone signaling results in an increase in insulin-stimulated glucose disposal, enhanced expression of the genes encoding adiponectin receptors, and coding for factors connected with mitochondrial function and FA oxidation in the muscles of patients with diabetes [332]. This evidence concerns the gene INS and diabetes mellitus.